196 related articles for article (PubMed ID: 32522167)
1. Cancer development and mortality differences in patients with glomerulonephritis after renal biopsy: a single center retrospective cohort study.
Ryu H; Kim K; Ryu J; Son HE; Ryu JY; Kim S; Na KY; Chae DW; Chin HJ;
BMC Nephrol; 2020 Jun; 21(1):221. PubMed ID: 32522167
[TBL] [Abstract][Full Text] [Related]
2. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
3. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases.
Lee H; Kim DK; Oh KH; Joo KW; Kim YS; Chae DW; Kim S; Chin HJ
Am J Nephrol; 2013; 37(1):74-83. PubMed ID: 23343855
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and predictors for ESRD and mortality in primary GN.
Chou YH; Lien YC; Hu FC; Lin WC; Kao CC; Lai CF; Chiang WC; Lin SL; Tsai TJ; Wu KD; Chen YM
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1401-8. PubMed ID: 22798538
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
Chou YH; Lin WC; Chen YM
Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
[TBL] [Abstract][Full Text] [Related]
7. Quantification of cancer risk in glomerulonephritis.
Heaf JG; Hansen A; Laier GH
BMC Nephrol; 2018 Feb; 19(1):27. PubMed ID: 29394927
[TBL] [Abstract][Full Text] [Related]
8. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy.
Ryu J; Ryu H; Kim S; Chin HJ; Na KY; Chae DW; Yoon HJ
PLoS One; 2019; 14(10):e0224024. PubMed ID: 31626671
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Glomerulonephritis in Renal Transplantation: Experience in Our Renal Transplantation Center.
Cañas L; López D; Pérez JF; Bancu I; Juega J; Ariza A; Bonet J; Lauzurica R
Transplant Proc; 2015 Oct; 47(8):2354-6. PubMed ID: 26518925
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic Position and Incidence of Glomerular Diseases.
Canney M; Induruwage D; Sahota A; McCrory C; Hladunewich MA; Gill J; Barbour SJ
Clin J Am Soc Nephrol; 2020 Mar; 15(3):367-374. PubMed ID: 32079609
[TBL] [Abstract][Full Text] [Related]
12. End-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population.
Sim JJ; Bhandari SK; Batech M; Hever A; Harrison TN; Shu YH; Kujubu DA; Jonelis TY; Kanter MH; Jacobsen SJ
Mayo Clin Proc; 2018 Feb; 93(2):167-178. PubMed ID: 29395351
[TBL] [Abstract][Full Text] [Related]
13. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.
Mirioglu S; Caliskan Y; Goksoy Y; Gulcicek S; Ozluk Y; Sarihan I; Seyahi N; Kilicaslan I; Turkmen A; Sever MS
Int Urol Nephrol; 2017 Dec; 49(12):2265-2272. PubMed ID: 29039058
[TBL] [Abstract][Full Text] [Related]
14. De novo glomerulonephritis in renal allografts with hepatitis C virus infection.
Ozdemir BH; Ozdemir FN; Sezer S; Colak T; Haberal M
Transplant Proc; 2006 Mar; 38(2):492-5. PubMed ID: 16549157
[TBL] [Abstract][Full Text] [Related]
15. Incidence of glomerulonephritis and non-diabetic end-stage renal disease in a developing middle-east region near armed conflict.
Ali AA; Sharif DA; Almukhtar SE; Abd KH; Saleem ZSM; Hughson MD
BMC Nephrol; 2018 Oct; 19(1):257. PubMed ID: 30305040
[TBL] [Abstract][Full Text] [Related]
16. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
OʼShaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Transplantation; 2017 Oct; 101(10):2636-2647. PubMed ID: 28207635
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Kidney Transplantation in Patients With Biopsy-Proven Glomerulonephritis.
Park H; Park WY; Kang SS; Yeo SM; Han S; Park SB; Jin K
Transplant Proc; 2018 May; 50(4):1009-1012. PubMed ID: 29731057
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence and improved prognosis of glomerulonephritis: a national 30-year study.
Heaf JG; Sørensen SS; Hansen A
Clin Kidney J; 2021 Jun; 14(6):1594-1602. PubMed ID: 34084455
[TBL] [Abstract][Full Text] [Related]
19. The incidence of biopsy-proven primary glomerulonephritis in the Republic of Macedonia-long-term follow-up.
Polenakovic MH; Grcevska L; Dzikova S
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v26-7. PubMed ID: 12817063
[TBL] [Abstract][Full Text] [Related]
20. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
Hariharan S; Adams MB; Brennan DC; Davis CL; First MR; Johnson CP; Ouseph R; Peddi VR; Pelz CJ; Roza AM; Vincenti F; George V
Transplantation; 1999 Sep; 68(5):635-41. PubMed ID: 10507481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
